These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21693170)

  • 21. Recent developments of steroid sulfatase inhibitors as anti-cancer agents.
    Foster PA; Reed MJ; Purohit A
    Anticancer Agents Med Chem; 2008 Oct; 8(7):732-8. PubMed ID: 18855575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.
    Stanway SJ; Purohit A; Woo LW; Sufi S; Vigushin D; Ward R; Wilson RH; Stanczyk FZ; Dobbs N; Kulinskaya E; Elliott M; Potter BV; Reed MJ; Coombes RC
    Clin Cancer Res; 2006 Mar; 12(5):1585-92. PubMed ID: 16533785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of steroid sulfatase with 4-substituted estrone and estradiol derivatives.
    Phan CM; Liu Y; Kim BM; Mostafa Y; Taylor SD
    Bioorg Med Chem; 2011 Oct; 19(20):5999-6005. PubMed ID: 21925885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase.
    Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D
    Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of steroid sulfatase in the MC3T3-E1 mouse pre-osteoblastic cell line.
    Selcer KW; Difrancesca HM
    Steroids; 2012 May; 77(6):696-702. PubMed ID: 22426324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid sulfatase and estrogen sulfotransferase in human carcinomas.
    Suzuki T; Miki Y; Nakamura Y; Ito K; Sasano H
    Mol Cell Endocrinol; 2011 Jul; 340(2):148-53. PubMed ID: 21073915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.
    Palmieri C; Januszewski A; Stanway S; Coombes RC
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):179-83. PubMed ID: 21342037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
    Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
    J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.
    Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A
    Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
    Ciobanu LC; Boivin RP; Luu-The V; Labrie F; Poirier D
    J Med Chem; 1999 Jun; 42(12):2280-6. PubMed ID: 10377235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Boronic acids as inhibitors of steroid sulfatase.
    Ahmed V; Liu Y; Silvestro C; Taylor SD
    Bioorg Med Chem; 2006 Dec; 14(24):8564-73. PubMed ID: 16973364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.
    Ahmed S; Owen CP; James K; Sampson L; Patel CK
    Curr Med Chem; 2002 Jan; 9(2):263-73. PubMed ID: 11860358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of steroid sulfatase in steroid homeostasis and characterization of the sulfated steroid pathway: Evidence from steroid sulfatase deficiency.
    Sánchez-Guijo A; Neunzig J; Gerber A; Oji V; Hartmann MF; Schuppe HC; Traupe H; Bernhardt R; Wudy SA
    Mol Cell Endocrinol; 2016 Dec; 437():142-153. PubMed ID: 27531568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steroid sulfatase inhibitors: the current landscape.
    Anbar HS; Isa Z; Elounais JJ; Jameel MA; Zib JH; Samer AM; Jawad AF; El-Gamal MI
    Expert Opin Ther Pat; 2021 Jun; 31(6):453-472. PubMed ID: 33783295
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
    Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
    J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
    Walter G; Liebl R; von Angerer E
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.
    Fournier D; Poirier D
    Eur J Med Chem; 2011 Sep; 46(9):4227-37. PubMed ID: 21782294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
    Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
    Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
    Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
    Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.